Articles by Kamran Zamanian

31. MDR's Impact On The European Trauma Device Market 7/20/2020

    The MDR could prove detrimental to the EU trauma device market, while COVID-19’s impact should be minimal. Will key market drivers be enough to prompt growth?    

32. Paclitaxel-Coated Medical Device Markets Recovering After Difficult Year 7/6/2020

    Despite recent positive evidence validating the use of paclitaxel in the peripheries, sales of devices that incorporate paclitaxel remain low. However, a turnaround appears to be on the horizon.

33. U.S. Bone Repair Devices: Trochanteric Grip Market Stalls, Cerclage Cables Take Off 8/7/2019

    Approximately 75,000 procedures were completed in 2018 using cerclage cables and trochanteric grips, devices used in the repair of broken or surgically altered bones. This procedure volume is increasing every year.

34. 4K Operating Room Technology Advancing, Despite Initial Doubts 8/8/2018

    As the minimally invasive approach continues to become standard procedure, demand for surgical visualization equipment will continue to rise. Continued adoption of 4k technology is bolstering growth in the total U.S. video and integrated operating room equipment market, which currently is valued at almost $2.3 billion.

35. The Taiwanese Bone Graft Substitute Market: A Small, But Profitable Target 10/3/2017

    With less than 25 million residents, Taiwan flies under the radar of many medical device manufacturers. However, the low penetration rate of bone graft substitutes and a rapidly aging population, make Taiwan a potentially lucrative target for orthopedic biomaterial manufacturers considering expansion in the Asia Pacific region.

36. Traditional, MIS European Spine Devices Experiencing Continual Growth 7/28/2017

    Traditional spinal fusion device markets continue to experience regular growth. This trend is applied across fixation devices, interbody devices, vertebral compression fracture (VCF) treatment, and other product segments. The major competitive limiters are expected to be minimally invasive devices and motion preservation. However, traditional devices currently enjoy a strong advantage over the latter in reimbursement and clinical research.

37. U.S. Cancer Epidemic Leads To Strong Growth In Cancer Treatment Market 3/3/2016

    The American market for interventional oncology (IO) devices is a large, diverse, and changing, encompassing many different methodological approaches to the treatment of cancer. As the potential client base increases, avenues for growth will be presented. However, competition between the different modalities will be stiff.